Global Non-invasive Prenatal Testing Market Report 2024

Non-invasive Prenatal Testing Global Market Report 2024 – By Type (Consumables, Instruments), By Application (Trisomy, Microdeletion, Genetics, Rh factor), By End User (Hospital, Diagnostic Labs) – Market Size, Trends, And Global Forecast 2024-2033

Starting Price : $5000.00 | Pages : 175 | Published : January 2024 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options
Request Sample
Request For Discount
FAQs

Need assistance or more information before the purchase?

Enquire Before Buying
Non-invasive Prenatal Testing Market

Proud Members Of

checkslacipN checkaoirsN checkscipN
Description Table Of Contents Tables & Figures Market Insights Related Reports

Non-Invasive Prenatal Testing Market Definition And Segments

Non-invasive prenatal testing is a test in which blood from the mother is drawn and tested for possible abnormalities in the patient. Non-invasive prenatal testing kits and equipment are used to diagnose genetic abnormalities, mainly chromosome defects, in fetuses in the first trimester of pregnancy.

The main types of non-invasive prenatal testing are consumables, and instruments. Consumables are products that are used up or depleted throughout their use. The various instrument used are NGS systems, PCR instruments, microarrays, ultrasound devices, and others (centrifuges, UV systems, incubators, microscopes) and the different consumables include assay kits and reagents, disposables. The applications involve trisomy, microdeletion, genetics, Rh factor that are used by hospitals and diagnostic labs.

The non-invasive prenatal testing market covered in this report is segmented –

1) By Type: Consumables, Instruments

2) By Application: Trisomy, Microdeletion, Genetics, Rh factor

3) By End User: Hospital, Diagnostic Labs

Subsegment: NGS Systems, PCR Instruments, Microarrays, Ultrasound Devices, Others(Centrifuges, UV Systems, Incubators, Microscopes), Assay Kits &Reagents, Disposables

The non-invasive prenatal testing market size has grown rapidly in recent years. It will grow from $4.73 billion in 2023 to $5.44 billion in 2024 at a compound annual growth rate (CAGR) of 15.1%. The growth in the historic period can be attributed to improved accuracy, reduced risk, increased maternal age, growing awareness, clinical guidelines.

The non-invasive prenatal testing market size is expected to see rapid growth in the next few years. It will grow to $9.43 billion in 2028 at a compound annual growth rate (CAGR) of 14.7%. The growth in the forecast period can be attributed to expanding test offerings, wider accessibility, rising maternal age, fetal anomaly detection, telemedicine and digital health. Major trends in the forecast period include expanded test panels, wider adoption of nipt, technological advancements, non-invasive fetal aneuploidy diagnosis (nifad).

Elevated Down Syndrome Incidence And Maternal Age Is Fueling Growth In Non-Invasive Prenatal Testing Market

High incidence rate of Down syndrome is one major factor driving non-invasive prenatal testing market with increase in average maternal age which has led to a concern on the safety about the growth of the fetus. Down syndrome is a chromosomal condition that occurs when an error in cell division results in an extra chromosome 21 and can affect the fetus cognitive ability and physical growth. The NIPT screening tests do not harm the mother or baby, carries no risk of miscarriage as they are non-invasive, and can detect more than 99% of cases of Down syndrome. According to National Down Syndrome Society and Centers for Disease control and Prevention, in the USA, 1 in every 700 babies are born with Down syndrome and 80% of children with Down syndrome are born to older mothers. The increased risk of having babies with Down syndrome among older women drives the growth of the non-invasive prenatal testing market.

The Role Of Increasing Maternal Age In Driving Non-Invasive Prenatal Testing Market Growth

Increasing maternal age is expected to drive the growth of the non-invasive prenatal testing market going forward. The increase in maternal age is influenced by factors such as pursuing education, career, financial stability, personal choice, delayed marriage, improved contraception, and societal changes, allowing women to make more informed decisions about family planning. As women delay childbirth, there's a higher risk of chromosomal abnormalities, prompting more expectant mothers to opt for NIPT to assess the health of their pregnancies. For instance, in June 2023, according to a report published by Centers for Disease Control and Prevention, the provisional birth rate for women between the ages of 35 and 39 increased by 2% from 2021 (53.7) to 54.9 births per 1,000 women in 2022. Additionally, the number of births to women in their late 30s experienced a 2% rise from 2021 to 2022. In 2022, the provisional birth rate for women aged 40-44 increased by 4% from 2021, reaching 12.5 births per 1,000 women, up from 12.0. The rate for this age group has shown nearly continuous growth from 1985 through 2021 (3.8). Furthermore, the number of births to these women increased by 6% from 2021 to 2022. In 2022, the provisional birth rate for women aged 45-49 (including those aged 50 and older) increased to 1.1 births per 1,000 women, up from 0.9 in 2021. This marked the first change in this rate since 2015. Furthermore, the number of births to women in this age group surged by 12% from 2021 to 2022. Therefore, increasing maternal age will continue to propel the growth of the non-invasive prenatal testing market in the forecast period.

Major companies operating in the non-invasive prenatal testing market include F. Hoffmann-La Roche AG, Illumina Inc., Laboratory Corporation of America Holdings, Natera Inc., PerkinElmer Inc., Quest Diagnostics Inc., Agilent Technologies Inc., BGI Diagnosis Co Ltd., Berry Genomics Co, LifeCodexx AG, Myriad Genetics Inc., NIPD Genetics Co Ltd., Sequenom Inc., Annoroad Gene Technology Co Ltd., Centogene AG, Counsyl Inc., EUROFINS Genoma Group, Eurofins Scientific SE, Next Biosciences, Premaitha Health PLC, Ariosa Diagnostics Inc., Beijing Genomics Institute, Yourgene Health PLC, GE Healthcare Technologies Inc., Koninklijke Philips NV, Thermo Fisher Scientific Inc., Pacific Biosciences of California Inc., QIAGEN NV, MedGenome Labs Ltd., Progenity Inc.

Ethical Dilemmas And Regulatory Challenges Impacting The Non-Invasive Prenatal Testing (NIPT) Market

The ethical hurdles in the non-invasive prenatal testing (NIPT) market have led to a range of ethical issues in terms of sex selection or aborting babies with chromosomal abnormality. Determining the sex of the fetus or knowing if the baby has an abnormality at an earlier stage led to abortions and resulted as an ethical issue which further led to strict regulations on using such devices. According to the official statistics provided by the UK government, a record 214,869 abortions were performed in the England and Wales in 2021 which was the highest sinch abortion became legal in 1967.. These hurdles will restrain the non-invasive prenatal testing market.

Advancements In Next-Generation Sequencing Transforming Research And Non-Invasive Prenatal Testing

Next-generation sequencing has increased the throughput, scalability, and speed, and further enables researchers to perform a wide range of applications and study biological systems at a higher level. Next-generation sequencing is a platform that has enabled the sequencing of thousands to millions of DNA molecules simultaneously. The manufacturers have introduced this technology to reduce the time and money required and optimizes the output to generate results regarding genome, and DNA testing. Major companies such as Illumina, Eurofins, Natera, Roche, and Annoroad have implemented this technology in non-invasive prenatal testing. CFDA (China Food and Drug Administration) has approved the medical instrument product registration of NGS instrument NextSeq 550AR produced by Annoroad.

Regulatory Frameworks And Requirements In The Non-Invasive Prenatal Testing Market

The non-invasive prenatal testing market is regulated by several regulations that are governed by multiple international and country-specific agencies. For instance, the US Food and Drug Administration (FDA) that issues Laboratory Developed Tests (LDTs) certification and Clinical Laboratory Improvement Amendments (CLIA) certification. The manufacturer needs to obtain a 510(k) premarket notification for in vitro diagnostic test. LDTs and CLIA certification are based on number of tests done during clinical trials. For example, For trisomy 21 (Down syndrome), there is an incidence of 1/1000. Given a target of 100 positive results, at least 100,000 samples would have to be tested to meet the requirements of a 510k. A 510k premarket notification demonstrates that the new product is at least as safe and effective as another legally-marketed device. It is mandatory for manufacturers to register a premarket notification before a new product can be certified as fit for market commercially.

Echelon Acquired Cradle Genomics

In May 2021, Echelon Diagnostics a US-based leading provider of genomic healthcare AI imaging analysis and big data solutions signed a collaboration agreement with Cradle Genomics for an undisclosed amount. This partnership that will help accelerate the development of Cradle’s cellular-based non-invasive prenatal diagnostic (NIPD) products. Cradle Genomics is a US-based that provides diagnostic solutions, specialized in the non-invasive prenatal testing services.

North America was the largest region in the non-invasive prenatal testing market in 2023. Western Europe was the second largest region in the non-invasive prenatal testing market. The regions covered in the non-invasive prenatal testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the non-invasive prenatal testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada

The non-invasive prenatal testing market includes revenue earned by ultrasound detection, fetal cells in maternal blood tests, cell-free DNA in maternal plasma tests, and biochemical screening tests. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The non-invasive prenatal testing market research report is one of a series of new reports from The Business Research Company that provides non-invasive prenatal testing market statistics, including non-invasive prenatal testing industry global market size, regional shares, competitors with a non-invasive prenatal testing market share, detailed non-invasive prenatal testing market segments, market trends and opportunities, and any further data you may need to thrive in the non-invasive prenatal testing industry. This non-invasive prenatal testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Non-invasive Prenatal Testing Market Report Scope
Report AttributeDetails
Market Size Value In 2024 $5.44 billion
Revenue Forecast In 2033 $9.43 billion
Growth Rate CAGR of 14.7% from 2024 to 2033
Base Year For Estimation 2023
Actual Estimates/Historical Data 2018-2023
Forecast Period 2024 - 2028 - 2033
Market Representation Revenue in USD Billion and CAGR from 2024 to 2033
Segments Covered 1) By Type: Consumables, Instruments
2) By Application: Trisomy, Microdeletion, Genetics, Rh factor
3) By End User: Hospital, Diagnostic Labs

Subsegment:: NGS Systems, PCR Instruments, Microarrays, Ultrasound Devices, Others(Centrifuges, UV Systems, Incubators, Microscopes), Assay Kits &Reagents, Disposables
Regional Scope Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Country Scope Australia; China; India; Indonesia; Japan; South Korea; Bangladesh; Thailand; Vietnam; Malaysia; Singapore; Philippines; Hong Kong; New Zealand; USA; Canada; Mexico; Brazil; Chile; Argentina; Colombia; Peru; France; Germany; UK; Austria; Belgium; Denmark; Finland; Ireland; Italy; Netherlands; Norway; Portugal; Spain; Sweden; Switzerland; Russia; Czech Republic; Poland; Romania; Ukraine; Saudi Arabia; Israel; Iran; Turkey; UAE; Egypt; Nigeria; South Africa
Key Companies Profiled F. Hoffmann-La Roche AG; Illumina Inc.; Laboratory Corporation of America Holdings; Natera Inc.; PerkinElmer Inc.; Quest Diagnostics Inc.; Agilent Technologies Inc.; BGI Diagnosis Co Ltd.; Berry Genomics Co; LifeCodexx AG; Myriad Genetics Inc.; NIPD Genetics Co Ltd.; Sequenom Inc.; Annoroad Gene Technology Co Ltd.; Centogene AG; Counsyl Inc.; EUROFINS Genoma Group; Eurofins Scientific SE; Next Biosciences; Premaitha Health Plc; Ariosa Diagnostics Inc.; Beijing Genomics Institute; Yourgene Health PLC; GE Healthcare Technologies Inc.; Koninklijke Philips NV; Thermo Fisher Scientific Inc.; Pacific Biosciences of California Inc.; QIAGEN NV; MedGenome Labs Ltd.; Progenity Inc.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Non-invasive Prenatal Testing Market Characteristics

    3. Non-invasive Prenatal Testing Market Trends And Strategies

    4. Non-invasive Prenatal Testing Market - Macro Economic Scenario

    4.1. Impact Of High Inflation On the Market

    4.2. Ukraine-Russia War Impact On the Market

    4.3. COVID-19 Impact On the Market

    5. Global Non-invasive Prenatal Testing Market Size and Growth

    5.1. Global Non-invasive Prenatal Testing Market Drivers and Restraints

    5.1.1. Drivers Of The Market

    5.1.2. Restraints Of The Market

    5.2. Global Non-invasive Prenatal Testing Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)

    5.3. Global Non-invasive Prenatal Testing Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

    6. Non-invasive Prenatal Testing Market Segmentation

    6.1. Global Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Consumables

    Instruments

    6.2. Global Non-invasive Prenatal Testing Market, Segmentation By Instruments, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    NGS Systems

    Polymerase Chain Reaction (PCR) Instruments

    Microarrays

    Ultrasound Devices

    Others(Centrifuges

    6.3. Global Non-invasive Prenatal Testing Market, Segmentation By Consumables, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Assay Kits And Reagents

    Disposables

    6.4. Global Non-invasive Prenatal Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Trisomy

    Microdeletion

    Genetics

    Rh factor

    6.5. Global Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Hospital

    Diagnostic Labs

    7. Non-invasive Prenatal Testing Market Regional And Country Analysis

    7.1. Global Non-invasive Prenatal Testing Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    7.2. Global Non-invasive Prenatal Testing Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8. Asia-Pacific Non-invasive Prenatal Testing Market

    8.1. Asia-Pacific Non-invasive Prenatal Testing Market Overview

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.3. Asia-Pacific Non-invasive Prenatal Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.4. Asia-Pacific Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    9. China Non-invasive Prenatal Testing Market

    9.1. China Non-invasive Prenatal Testing Market Overview

    9.2. China Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.3. China Non-invasive Prenatal Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.4. China Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    10. India Non-invasive Prenatal Testing Market

    10.1. India Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.2. India Non-invasive Prenatal Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.3. India Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11. Japan Non-invasive Prenatal Testing Market

    11.1. Japan Non-invasive Prenatal Testing Market Overview

    11.2. Japan Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.3. Japan Non-invasive Prenatal Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.4. Japan Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12. Australia Non-invasive Prenatal Testing Market

    12.1. Australia Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.2. Australia Non-invasive Prenatal Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.3. Australia Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13. Indonesia Non-invasive Prenatal Testing Market

    13.1. Indonesia Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.2. Indonesia Non-invasive Prenatal Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.3. Indonesia Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14. South Korea Non-invasive Prenatal Testing Market

    14.1. South Korea Non-invasive Prenatal Testing Market Overview

    14.2. South Korea Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.3. South Korea Non-invasive Prenatal Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.4. South Korea Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15. Western Europe Non-invasive Prenatal Testing Market

    15.1. Western Europe Non-invasive Prenatal Testing Market Overview

    15.2. Western Europe Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.3. Western Europe Non-invasive Prenatal Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.4. Western Europe Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16. UK Non-invasive Prenatal Testing Market

    16.1. UK Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.2. UK Non-invasive Prenatal Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.3. UK Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17. Germany Non-invasive Prenatal Testing Market

    17.1. Germany Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.2. Germany Non-invasive Prenatal Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.3. Germany Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18. France Non-invasive Prenatal Testing Market

    18.5. France Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.6. France Non-invasive Prenatal Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.7. France Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19. Italy Non-invasive Prenatal Testing Market

    19.9. Italy Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.10. Italy Non-invasive Prenatal Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.11. Italy Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20. Spain Non-invasive Prenatal Testing Market

    20.13. Spain Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.14. Spain Non-invasive Prenatal Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.15. Spain Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21. Eastern Europe Non-invasive Prenatal Testing Market

    21.1. Eastern Europe Non-invasive Prenatal Testing Market Overview

    21.2. Eastern Europe Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.3. Eastern Europe Non-invasive Prenatal Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.4. Eastern Europe Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22. Russia Non-invasive Prenatal Testing Market

    22.1. Russia Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.2. Russia Non-invasive Prenatal Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.3. Russia Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23. North America Non-invasive Prenatal Testing Market

    23.1. North America Non-invasive Prenatal Testing Market Overview

    23.2. North America Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.3. North America Non-invasive Prenatal Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.4. North America Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24. USA Non-invasive Prenatal Testing Market

    24.1. USA Non-invasive Prenatal Testing Market Overview

    24.2. USA Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.3. USA Non-invasive Prenatal Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.4. USA Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25. Canada Non-invasive Prenatal Testing Market

    25.1. Canada Non-invasive Prenatal Testing Market Overview

    25.2. Canada Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.3. Canada Non-invasive Prenatal Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.4. Canada Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26. South America Non-invasive Prenatal Testing Market

    26.1. South America Non-invasive Prenatal Testing Market Overview

    26.2. South America Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.3. South America Non-invasive Prenatal Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.4. South America Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27. Brazil Non-invasive Prenatal Testing Market

    27.1. Brazil Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.2. Brazil Non-invasive Prenatal Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.3. Brazil Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28. Middle East Non-invasive Prenatal Testing Market

    28.1. Middle East Non-invasive Prenatal Testing Market Overview

    28.2. Middle East Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.3. Middle East Non-invasive Prenatal Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.4. Middle East Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29. Africa Non-invasive Prenatal Testing Market

    29.1. Africa Non-invasive Prenatal Testing Market Overview

    29.2. Africa Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.3. Africa Non-invasive Prenatal Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.4. Africa Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    30. Non-invasive Prenatal Testing Market Competitive Landscape And Company Profiles

    30.1. Non-invasive Prenatal Testing Market Competitive Landscape

    30.2. Non-invasive Prenatal Testing Market Company Profiles

    30.2.1. F. Hoffmann-La Roche AG

    30.2.1.1. Overview

    30.2.1.2. Products and Services

    30.2.1.3. Strategy

    30.2.1.4. Financial Performance

    30.2.2. Illumina Inc.

    30.2.2.1. Overview

    30.2.2.2. Products and Services

    30.2.2.3. Strategy

    30.2.2.4. Financial Performance

    30.2.3. Laboratory Corporation of America Holdings

    30.2.3.1. Overview

    30.2.3.2. Products and Services

    30.2.3.3. Strategy

    30.2.3.4. Financial Performance

    30.2.4. Natera Inc.

    30.2.4.1. Overview

    30.2.4.2. Products and Services

    30.2.4.3. Strategy

    30.2.4.4. Financial Performance

    30.2.5. PerkinElmer Inc

    30.2.5.1. Overview

    30.2.5.2. Products and Services

    30.2.5.3. Strategy

    30.2.5.4. Financial Performance

    31. Global Non-invasive Prenatal Testing Market Competitive Benchmarking

    32. Global Non-invasive Prenatal Testing Market Competitive Dashboard

    33. Key Mergers And Acquisitions In The Non-invasive Prenatal Testing Market

    34. Non-invasive Prenatal Testing Market Future Outlook and Potential Analysis

    34.1 Non-invasive Prenatal Testing Market In 2028 - Countries Offering Most New Opportunities

    34.2 Non-invasive Prenatal Testing Market In 2028 - Segments Offering Most New Opportunities

    34.3 Non-invasive Prenatal Testing Market In 2028 - Growth Strategies

    34.3.1 Market Trend Based Strategies

    34.3.2 Competitor Strategies

    35. Appendix

    35.1. Abbreviations

    35.2. Currencies

    35.3. Historic And Forecast Inflation Rates

    35.4. Research Inquiries

    35.5. The Business Research Company

    35.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Table 3: Global Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 4: Global Non-invasive Prenatal Testing Market, Segmentation By Instruments, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 5: Global Non-invasive Prenatal Testing Market, Segmentation By Consumables, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 6: Global Non-invasive Prenatal Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 7: Global Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 8: Global Non-invasive Prenatal Testing Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 9: Global Non-invasive Prenatal Testing Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 10: Asia-Pacific, Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 11: Asia-Pacific, Non-invasive Prenatal Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 12: Asia-Pacific, Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 13: China, Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 14: China, Non-invasive Prenatal Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 15: China, Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 16: India, Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 17: India, Non-invasive Prenatal Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 18: India, Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 19: Japan, Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 20: Japan, Non-invasive Prenatal Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 21: Japan, Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 22: Australia, Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 23: Australia, Non-invasive Prenatal Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 24: Australia, Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 25: Indonesia, Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 26: Indonesia, Non-invasive Prenatal Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 27: Indonesia, Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 28: South Korea, Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 29: South Korea, Non-invasive Prenatal Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 30: South Korea, Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 31: Western Europe, Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 32: Western Europe, Non-invasive Prenatal Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 33: Western Europe, Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 34: UK, Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 35: UK, Non-invasive Prenatal Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 36: UK, Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 37: Germany, Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 38: Germany, Non-invasive Prenatal Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 39: Germany, Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 40: France, Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 41: France, Non-invasive Prenatal Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 42: France, Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 43: Italy, Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 44: Italy, Non-invasive Prenatal Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 45: Italy, Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 46: Spain, Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 47: Spain, Non-invasive Prenatal Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 48: Spain, Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 49: Eastern Europe, Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 50: Eastern Europe, Non-invasive Prenatal Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 51: Eastern Europe, Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 52: Russia, Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 53: Russia, Non-invasive Prenatal Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 54: Russia, Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 55: North America, Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 56: North America, Non-invasive Prenatal Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 57: North America, Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 58: USA, Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 59: USA, Non-invasive Prenatal Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 60: USA, Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 61: Canada, Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 62: Canada, Non-invasive Prenatal Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 63: Canada, Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 64: South America, Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 65: South America, Non-invasive Prenatal Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 66: South America, Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 67: Brazil, Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 68: Brazil, Non-invasive Prenatal Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 69: Brazil, Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 70: Middle East, Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 71: Middle East, Non-invasive Prenatal Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 72: Middle East, Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 73: Africa, Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 74: Africa, Non-invasive Prenatal Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 75: Africa, Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 76: F. Hoffmann-La Roche AG Financial Performance
  • Table 77: Illumina Inc. Financial Performance
  • Table 78: Laboratory Corporation of America Holdings Financial Performance
  • Table 79: Natera Inc. Financial Performance
  • Table 80: PerkinElmer Inc Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Figure 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Figure 3: Global Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 4: Global Non-invasive Prenatal Testing Market, Segmentation By Instruments, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 5: Global Non-invasive Prenatal Testing Market, Segmentation By Consumables, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 6: Global Non-invasive Prenatal Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 7: Global Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 8: Global Non-invasive Prenatal Testing Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 9: Global Non-invasive Prenatal Testing Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 10: Asia-Pacific, Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 11: Asia-Pacific, Non-invasive Prenatal Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 12: Asia-Pacific, Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 13: China, Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 14: China, Non-invasive Prenatal Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 15: China, Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 16: India, Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 17: India, Non-invasive Prenatal Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 18: India, Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 19: Japan, Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 20: Japan, Non-invasive Prenatal Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 21: Japan, Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 22: Australia, Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 23: Australia, Non-invasive Prenatal Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 24: Australia, Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 25: Indonesia, Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 26: Indonesia, Non-invasive Prenatal Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 27: Indonesia, Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 28: South Korea, Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 29: South Korea, Non-invasive Prenatal Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 30: South Korea, Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 31: Western Europe, Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 32: Western Europe, Non-invasive Prenatal Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 33: Western Europe, Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 34: UK, Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 35: UK, Non-invasive Prenatal Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 36: UK, Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 37: Germany, Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 38: Germany, Non-invasive Prenatal Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 39: Germany, Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 40: France, Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 41: France, Non-invasive Prenatal Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 42: France, Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 43: Italy, Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 44: Italy, Non-invasive Prenatal Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 45: Italy, Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 46: Spain, Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 47: Spain, Non-invasive Prenatal Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 48: Spain, Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 49: Eastern Europe, Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 50: Eastern Europe, Non-invasive Prenatal Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 51: Eastern Europe, Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 52: Russia, Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 53: Russia, Non-invasive Prenatal Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 54: Russia, Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 55: North America, Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 56: North America, Non-invasive Prenatal Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 57: North America, Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 58: USA, Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 59: USA, Non-invasive Prenatal Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 60: USA, Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 61: Canada, Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 62: Canada, Non-invasive Prenatal Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 63: Canada, Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 64: South America, Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 65: South America, Non-invasive Prenatal Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 66: South America, Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 67: Brazil, Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 68: Brazil, Non-invasive Prenatal Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 69: Brazil, Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 70: Middle East, Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 71: Middle East, Non-invasive Prenatal Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 72: Middle East, Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 73: Africa, Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 74: Africa, Non-invasive Prenatal Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 75: Africa, Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 76: F. Hoffmann-La Roche AG Financial Performance
  • Figure 77: Illumina Inc. Financial Performance
  • Figure 78: Laboratory Corporation of America Holdings Financial Performance
  • Figure 79: Natera Inc. Financial Performance
  • Figure 80: PerkinElmer Inc Financial Performance
Forecasting Till 2030: Opportunities And Strategies In The Global Value Based Care Payment Market – Includes Value Based Care Payment Market Analysis
Read More
How Will The Nuclear Medicine Market Grow In 2022?
Read More
What Is The Pediatric Imaging Market Overview In 2022?
Read More
Latest Healthcare Technology Management Market Growth Study 2022-2026 By The Business Research Company
Read More
The Business Research Company offers the hospital acquired infection control market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the multiplex assays market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the healthcare it consulting market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the renal biomarkers market research report 2022 with industry size, share, segments and market growth
Read More
Hormonal Contraceptives Global Market Report 2024 – By Product (Pills, Injectable Birth Control, Vaginal Rings, Others), By End User (Hospitals, Homecare Settings, Gynecology Centers, Clinics, Ambulatory Surgical Centers), By Hormones (Progestin-Only, Combined Hormones), By Distribution Channel (Drug Stores, Gynecology/ Fertility Clinics, E-Commerce, Other Distribution Channels) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Molecular Diagnostics Devices And Equipment Global Market Report 2024 – By Product (Instruments, Reagents And Consumables, Software), By Technology (DNA (Deoxyribonucleic acid) sequencing, Polymerase chain reaction, Isothermal Nucleic Acid Amplification Technology, Transcription Mediated Amplification (TMA), In situ hybridization, Microarrays, Mass spectrometry, Other Technologies), By Application (Cancer, Pharmacogenomics, Genetic testing, Infectious disease, Prenatal, Other Applications), By End User (Diagnostic laboratories, Hospitals, Other End Users) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Prenatal Testing & Newborn Screening Global Market Report 2024 – By Diagnostic Type (Non-Invasive, Invasive), By Technology (Screening Technology, Diagnostic Technology), By End user (Hospitals, Diagnostic centers) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Genetic Testing Global Market Report 2024 – By Type (Predictive Testing, Carrier Testing, Prenatal And Newborn Testing, Diagnostic Testing, Pharmacogenomics Testing, Nutrigenomic Testing, Other Types), By Technology (Cytogenetic Testing, Biochemical Testing, Molecular Testing), By Application (Cancer Diagnosis, Genetic Disease Diagnosis, Cardiovascular Disease Diagnosis, Other Applications), By End User (Hospitals And Clinics, Diagnostic Laboratories And Centers, Other End Users) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Point-of-Care Diagnostics Devices And Equipment Global Market Report 2024 – By Type (Infectious disease testing kits, Cardio metabolic monitoring kits,, Cholesterol testing kits, Pregnancy and fertility tests kits, Tumor/cancer markers, Urinalysis testing kits, Hematology testing kits, Drugs of abuse testing kits, Fecal occult testing kits, Other Types), By Prescription Mode (Prescription-based Testing Devices, Over-The-Counter (OTC) Testing Devices), By End User (Professional diagnostic centers, Hospitals/critical care centers, Outpatient healthcare Setting, Ambulatory care settings, Research laboratories, Home) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Cardiovascular Monitoring And Diagnostic Devices And Equipment Global Market Report 2024 – By Product Type (Cardiopulmonary Stress Testing Systems, ECG Data Management Systems, ECG Monitoring Equipment, ECG Stress Testing Systems, Event Monitoring Systems, Holter Monitoring Systems), By Type (Heart Disease, Coronary Heart Disease), By End-Use (Hospitals/Physician Clinic (Continuous Glucose Monitors), Home/Emergency, Research and Development (Clinical Trials, Universities, CRO)) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Metabolomics Global Market Report 2024 – By Product & Service (Metabolomics Instruments, Metabolomics Bioinformatics Tools & Services), By Indication (Cancer, Cardiovascular Disorders, Neurological Disorders, Inborn Errors of Metabolism, Other Indications), By Application (Biomarker Discovery, Drug Discovery, Toxicology Testing, Nutrigenomics, Functional Genomics, Personalized Medicine, Other Applications) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Hematology Diagnostic Devices And Equipment Global Market Report 2024 – By Product (Instruments, Consumables), By Instruments (Analyzers, Flow cytometers, Other Instruments), By Consumables (Reagents, Stains, Other Consumables), By Application (Drug Testing, Auto-Immune Disease, Cancer, Diabetes Mellitus, Infectious Disease, Other Applications), By End User (Hospitals, Specialized Diagnostic Centers, Specialized Research Institutes) – Market Size, Trends, And Global Forecast 2024-2033
View Report

Frequently Asked Questions

What is the definition of the non-invasive prenatal testing market?

Non-invasive prenatal testing is a test in which blood from the mother is drawn and tested for possible abnormalities in the patient. Non-invasive prenatal testing kits and equipment are used to diagnose genetic abnormalities, mainly chromosome defects, in fetuses in the first trimester of pregnancy. For further insights on the non-invasive prenatal testing market, request a sample here

How will the non-invasive prenatal testing market drivers and restraints affect the non-invasive prenatal testing market dynamics? What forces will shape the non-invasive prenatal testing industry going forward?

The non-invasive prenatal testing market major growth driver - elevated down syndrome incidence and maternal age is fueling growth in non-invasive prenatal testing market. For further insights on the non-invasive prenatal testing market, request a sample here

What is the forecast market size or the forecast market value of the non-invasive prenatal testing market ?

The non-invasive prenatal testing market size has grown rapidly in recent years. It will grow from $4.73 billion in 2023 to $5.44 billion in 2024 at a compound annual growth rate (CAGR) of 15.1%. The growth in the historic period can be attributed to improved accuracy, reduced risk, increased maternal age, growing awareness, clinical guidelines. The non-invasive prenatal testing market size is expected to see rapid growth in the next few years. It will grow to $9.43 billion in 2028 at a compound annual growth rate (CAGR) of 14.7%. The growth in the forecast period can be attributed to expanding test offerings, wider accessibility, rising maternal age, fetal anomaly detection, telemedicine and digital health. Major trends in the forecast period include expanded test panels, wider adoption of nipt, technological advancements, non-invasive fetal aneuploidy diagnosis (nifad). For further insights on the non-invasive prenatal testing market, request a sample here

How is the non-invasive prenatal testing market segmented?

The non-invasive prenatal testing market is segmented
1) By Type: Consumables; Instruments
2) By Application: Trisomy; Microdeletion; Genetics; Rh factor
3) By End User: Hospital; Diagnostic Labs Subsegment: NGS Systems; PCR Instruments; Microarrays; Ultrasound Devices; Others(Centrifuges; UV Systems; Incubators; Microscopes); Assay Kits &Reagents; Disposables For further insights on the non-invasive prenatal testing market, request a sample here

Which region has the largest share of the non-invasive prenatal testing market? What are the other regions covered in the report?

North America was the largest region in the non-invasive prenatal testing market in 2023. Western Europe was the second largest region in the non-invasive prenatal testing market. The regions covered in the non-invasive prenatal testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa For further insights on the non-invasive prenatal testing market, request a sample here.

Who are the major players in the non-invasive prenatal testing market?

Major companies operating in the non-invasive prenatal testing market include F. Hoffmann-La Roche AG, Illumina Inc., Laboratory Corporation of America Holdings, Natera Inc., PerkinElmer Inc., Quest Diagnostics Inc., Agilent Technologies Inc., BGI Diagnosis Co Ltd., Berry Genomics Co, LifeCodexx AG, Myriad Genetics Inc., NIPD Genetics Co Ltd., Sequenom Inc., Annoroad Gene Technology Co Ltd., Centogene AG, Counsyl Inc., EUROFINS Genoma Group, Eurofins Scientific SE, Next Biosciences, Premaitha Health Plc, Ariosa Diagnostics Inc., Beijing Genomics Institute, Yourgene Health PLC, GE Healthcare Technologies Inc., Koninklijke Philips NV, Thermo Fisher Scientific Inc., Pacific Biosciences of California Inc., QIAGEN NV, MedGenome Labs Ltd., Progenity Inc. For further insights on the non-invasive prenatal testing market, request a sample here.

What are the key trends in the non-invasive prenatal testing market?

Major trend in the non-invasive prenatal testing market - advancements in next-generation sequencing transforming research and non-invasive prenatal testing. For further insights on the non-invasive prenatal testing market, request a sample here.

What are the major opportunities in the non-invasive prenatal testing market? What are the strategies for the non-invasive prenatal testing market?

For detailed insights on the major opportunities and strategies in the non-invasive prenatal testing market, request a sample here.

How does the non-invasive prenatal testing market relate to the overall economy and other similar markets?

For detailed insights on non-invasive prenatal testing market's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the non-invasive prenatal testing industry?

For detailed insights on the mergers and acquisitions in the non-invasive prenatal testing industry, request a sample here.

What are the key dynamics influencing the non-invasive prenatal testing market growth? SWOT analysis of the non-invasive prenatal testing market.

For detailed insights on the key dynamics influencing the non-invasive prenatal testing market growth and SWOT analysis of the non-invasive prenatal testing industry, request a sample here.